# Xinlong Zheng

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xinlong-zheng/

## Facts

| Field | Value |
| --- | --- |
| Citations | 98 |
| Field | Lung Cancer Diagnosis and Treatment |
| h-index | 6 |
| i10-index | 4 |
| Last Known Institution | Shanghai Pulmonary Hospital |
| OpenAlex ID | https://openalex.org/A5029275525 |
| ORCID iD | 0000-0002-2461-2365 |
| Works | 34 |

## Researcher papers

- [Interaction between CAF and CD8+ T cells in non-small cell lung cancer affects prognosis and efficacy of immunotherapy.](https://scholariq.org/papers/interaction-between-caf-and-cd8-t-cells-in-non-small-cell-lung-cancer-affects/)
- [CD8+ T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types](https://scholariq.org/papers/cd8-t-cell-cancer-associated-fibroblast-ratio-stratifies-prognostic-and/)
- [Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis](https://scholariq.org/papers/effects-of-intrathecal-pemetrexed-on-the-survival-of-patients-with/)
- [Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer](https://scholariq.org/papers/cerebrospinal-fluid-circulating-tumor-dna-contributes-to-the-detection-and/)
- [Intrapulmonic Cavity or Necrosis on Baseline CT Scan Serves as an Efficacy Predictor of Anti-PD-(L)1 Inhibitor in Advanced Lung Squamous Cell Carcinoma](https://scholariq.org/papers/intrapulmonic-cavity-or-necrosis-on-baseline-ct-scan-serves-as-an-efficacy/)
- [Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study](https://scholariq.org/papers/baseline-c-reactive-protein-predicts-efficacy-of-the-first-line-immune/)
- [Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer](https://scholariq.org/papers/genomic-characterisation-of-de-novo-egfr-copy-number-gain-and-its-impact-on-the/)
- [UniCure: A Foundation Model for Predicting Personalized Cancer Therapy Response](https://scholariq.org/papers/unicure-a-foundation-model-for-predicting-personalized-cancer-therapy-response/)
- [A novel parameter reflecting the interaction between CD8+ T cells and cancer-associated fibroblasts.](https://scholariq.org/papers/a-novel-parameter-reflecting-the-interaction-between-cd8-t-cells-and-cancer/)
- [Tumour response heterogeneity as a powerful independent predictor of treatment outcome in advanced lung adenocarcinoma: a retrospective analysis](https://scholariq.org/papers/tumour-response-heterogeneity-as-a-powerful-independent-predictor-of-treatment/)
- [The comparison of chemotherapy and treatments according to NGS results in advanced lung adenocarcinoma patients resistant to EGFR-TKIs.](https://scholariq.org/papers/the-comparison-of-chemotherapy-and-treatments-according-to-ngs-results-in/)

## Researcher topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Shanghai Pulmonary Hospital](https://scholariq.org/institutions/shanghai-pulmonary-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.